Whole body positron emission tomography/computed tomography (PET/CT) tumour staging with integrated PET/CT colonography: technical feasibility and first experiences in patients with colorectal cancer

Veit, P.; Kühle, C.; Beyer, T.; Kuehl, H.; Herborn, C. U.; Börsch, G.; Stergar, H.; Barkhausen, J.; Bockisch, A.; Antoch, G.
January 2006
Gut;Jan2006, Vol. 55 Issue 1, p68
Academic Journal
Aim: The aim of this study was to implement an imaging protocol for positron emission tomography/ computed tomography (PET/CT) colonography and to combine this protocol with whole body PET/CT tumour staging for a single whole body examination for routine clinical use. Subjects and methods: A whole body PET/CT protocol for tumour staging and a protocol for PET/CT colonography were integrated into one examination. Fourteen prospective patients with suspected colorectal cancer underwent whole body PET/CT after aqueous bowel distension and pharmacological bowel relaxation. Colonoscopy and histopathology served as the standards of reference in all patients. Results: The modified PET/CT examination detected all but one lesion in the colon. One additional lesion was detected in a patient with incomplete colonoscopy due to high grade luminal stenosis. One polyp with malignant conversion was identified with the modified PET/CT protocol. PET/CT colonography proved accurate in local lymph node staging and staged nine out of 11 patients correctly. Six additional extracolonic tumour sites were detected based on the whole body staging approach. Conclusion: Whole body PET/CT with integrated colonography is technically feasible for whole body staging in patients with colorectal cancer. Based on these initial diagnostic experiences, this integrated protocol may be of substantial benefit in staging patients with colorectal cancer, focusing on patients with incomplete colonoscopy and those with small synchronous bowel lesions.


Related Articles

  • Imaging the L-Type Amino Acid Transporter-1 (LAT1) with Zr-89 ImmunoPET. Ikotun, Oluwatayo F.; Marquez, Bernadette V.; Huang, Chaofeng; Masuko, Kazue; Daiji, Miyamoto; Masuko, Takashi; McConathy, Jonathan; Lapi, Suzanne E. // PLoS ONE;Oct2013, Vol. 8 Issue 10, p1 

    The L-type amino acid transporter-1 (LAT1, SLC7A5) is upregulated in a wide range of human cancers, positively correlated with the biological aggressiveness of tumors, and a promising target for both imaging and therapy. Radiolabeled amino acids such as O-(2-[18F]fluoroethyl)-L-tyrosine (FET)...

  • Stellenwert der PET/CT zur Bildgebung des kolorektalen Karzinoms. Meinel, F.G.; Schramm, N.; Haug, A.R.; Graser, A.; Reiser, M.F.; Rist, C. // Der Radiologe;Jun2012, Vol. 52 Issue 6, p529 

    Clinical/methodical issue: Fluorodeoxyglucose-positron emission tomography/computed tomography (FDG-PET/CT) has emerged as a very useful imaging modality in the management of colorectal carcinoma. Data from the literature regarding the role of PET/CT in the initial diagnosis, staging,...

  • Management of local recurrence of colorectal cancer: the role of PET/CT. Bamba, Yoshiko; Itabashi, Michio; Kameoka, Shingo // Abdominal Imaging;May2011, Vol. 36 Issue 3, p322 

    im: The aim was to examine the clinical applicability of positron-emission tomography/computed tomography (PET/CT) for diagnosing local recurrence of colorectal cancer. Methods: From August 2003 to August 2008, 256 patients with colorectal cancer underwent PET/CT scanning for staging or...

  • Importance of Quantification for the Analysis of PET Data in Oncology: Review of Current Methods and Trends for the Future. Tomasi, Giampaolo; Turkheimer, Federico; Aboagye, Eric // Molecular Imaging & Biology;Apr2012, Vol. 14 Issue 2, p131 

    In oncology, positron emission tomography (PET) is an important tool for tumour diagnosis and staging, assessment of response to treatment and evaluation of the pharmacokinetic properties and efficacy of new drugs. Despite its quantitative potential, however, in daily clinical practice PET is...

  • Impact of attenuation correction on the accuracy of FDG-PET in patients with abdominal tumors: a free-response ROC analysis. Hustinx, Roland; Dolin, Ron J.; Bénard, Francois; Bhatnagar, Anish; Chakraborty, Dev; Smith, Robin J.; Jang, Sunyoung; Alavi, Abass // European Journal of Nuclear Medicine;2000, Vol. 27 Issue 9, p1365 

    Abstract. The aim of this study was to evaluate image quality and lesion detectability with and without attenuation correction in patients with abdominal tumors, using a free-response receiver operating characteristic (FROC) methodology. Thirty-four patients with various abdominal tumors were...

  • Colonography by CT, MRI and PET/CT combined with conventional colonoscopy in colorectal cancer screening and staging. Long Sun; Hua Wu; Yong-Song Guan; Fujishiro, Mitsuhiro // World Journal of Gastroenterology;2/14/2008, Vol. 14 Issue 6, p853 

    Colorectal cancer (CRC) remains a leading cancer killer worldwide. But the disease is both curable and preventable at an early stage. Regular CRC cancer screening has been shown to reduce the risk of dying from CRC. However, the importance of large-scale screening is only now starting to be...

  • How can research fields be integrated with PET imaging? Sugimura, Haruhiko // Gastric Cancer;Apr2013, Vol. 16 Issue 2, p118 

    A letter to the editor is presented regarding the integration of positron emission tomography (PET) imaging to research fields.

  • Utility of single photon emission tomography/computed tomography in characterizing an additional focus of iodine uptake in post-treatment whole body iodine scan. Mozhikunnam Chandran, Vinod Kumar; Soujya, Thomas; Balasubramanian Harisankar, Chidambaram Natrajan // Indian Journal of Nuclear Medicine;Apr/May2014, Vol. 29 Issue 2, p127 

    A letter to the editor is presented in response to the article related with single photon emission tomography.

  • Canadian province boosts PET/CT capacity. McCarty, Mark // Medical Device Daily;9/1/2011, Vol. 15 Issue 167, p8 

    The article reports that a new positron emission tomography - computed tomography (PET/CT) scanner will be installed by the government of British Columbia at the British Columbia Cancer Agency in Vancouver.


Read the Article


Sign out of this library

Other Topics